Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology*; D003024:Clozapine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism; D003984:Dibenzazepines / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D003984:Dibenzazepines; D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid; D003024:Clozapine; D006220:Haloperidol; D002746:Chlorpromazine